THERAVANCE BIOPHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.12 USD | -0.22% |
|
-2.36% | -18.86% |
| 12/04 | Sector Update: Health Care Stocks Lower Friday Afternoon | MT |
| 12/04 | Theravance Biopharma Shares Rise After BTIG Starts Coverage at Buy | MT |
Chart calendar Theravance Biopharma, Inc.
8c569f00049ba4e67d658c.ddTr6sot0n6Pnn-I4PerBxSWcrsZo6sXWkXUSN_vPmc.M6OiiIlhvRi9-D6lkJzvdk33HPohztpnPTLnCqqrbRAFstufhWGrFejSKg~91d2bc8de63851877b5a0a707ff18cf1
Upcoming events on Theravance Biopharma, Inc.
Past events on Theravance Biopharma, Inc.
| 18/04/2024 09:30 pm | Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference |
| 05/03/2024 09:00 pm | TD Cowen Health Care Conference |
| 27/02/2024 03:30 am | Q4 2023 Earnings Call |
| 27/02/2024 02:35 am | Q4 2023 Earnings Release |
| 08/01/2024 | JPMorgan Healthcare Conference |
| 29/11/2023 12:15 am | Evercore ISI HealthCONx Conference |
| 17/11/2023 04:30 am | American Autonomic Society Autonomic Nervous System International Symposium - Poster #95 |
| 08/11/2023 03:30 am | Q3 2023 Earnings Call |
| 08/11/2023 02:58 am | Q3 2023 Earnings Release |
| 12/09/2023 07:00 pm | H.C. Wainwright Global Investment Conference |
| 28/08/2023 04:30 pm | Parkinson Disease and Movement Disorders International Congress - Abstract No : 7 |
| 28/08/2023 04:30 pm | Parkinson Disease and Movement Disorders International Congress - Abstract No : 3 |
| 08/08/2023 02:30 am | Q2 2023 Earnings Call |
| 08/08/2023 01:35 am | Q2 2023 Earnings Release |
| 09/05/2023 02:30 am | Q1 2023 Earnings Call |
| 09/05/2023 01:35 am | Q1 2023 Earnings Release |
| 02/05/2023 04:30 pm | Annual General Meeting |
| 18/04/2023 01:15 am | Needham Healthcare Conference |
| 08/03/2023 09:00 pm | Cowen Health Care Conference |
| 28/02/2023 03:30 am | Q4 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 73,4 61,1 20.15% | 71,9 73,9 -2.71% | 55,3 53,7 3.02% | 51,3 51,8 -0.91% | 57,4 57,5 -0.06% | 70,7 |
|
EBITDA Million USD | Released Forecast Spread | -249 -242 -2.7% | -289 -254 -13.47% | -190 -193 1.54% | -48,5 -51,2 5.35% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -252 -246 -2.43% | -298 -289 -3.18% | -258 -232 -11.23% | -92,0 -88,9 -3.47% | -56,0 -59,4 5.69% | -29,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -242 -242 0.07% | -287 -282 -1.5% | -200 -186 -7.06% | -92,8 -58,9 -57.63% | -49,3 -54,4 9.35% | -23,9 |
|
Net income Million USD | Released Forecast Spread | -236 -236 0% | -278 -282 1.42% | -199 -186 -6.98% | 872 -60,1 1551.05% | -55,2 -53,9 -2.44% | -33,0 |
|
EPS USD | Released Forecast Spread | -4,25 -4,12 -3.16% | -4,46 -4,51 1.18% | -2,87 -2,63 -9.31% | 11,9 -0,83 1527.71% | -1,00 -0,97 -2.74% | -0,68 |
| Announcement Date | 24/02/20 | 23/02/21 | 23/02/22 | 27/02/23 | 26/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 14,9 13,6 10.22% | 13,2 14,5 -8.89% | 11,1 11,8 -6.38% | 12,5 11,8 5.43% | 14,6 15,7 -6.86% | 10,4 13,7 -23.98% | 13,7 15,4 -10.84% | 15,7 15,1 4.26% | 17,6 17,6 -0.06% | 14,0 | 16,1 | 17,1 | 23,6 | |
|
EBITDA Million USD | Released Forecast Spread | -37,9 -10,5 -261.48% | |||||||||||||
|
EBIT Million USD | Released Forecast Spread | -56,2 -39,2 -43.18% | -38,5 -24,8 -54.97% | -26,9 -9,94 -170.44% | -14,2 -14,9 4.8% | -17,4 -13,2 -32.18% | -24,9 -19,2 -29.99% | -16,1 -15,1 -6.65% | -8,76 -11,9 26.38% | -6,24 -9,62 35.12% | -10,4 | -9,75 | -8,80 | -0,46 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -32,2 -23,2 -38.69% | -25,4 -7,68 -231.05% | -8,20 20,4 -140.25% | -16,0 -0,74 -2053.63% | -14,3 -12,7 -12.38% | -22,5 -19,5 -15.01% | -14,2 -15,5 8.49% | -7,58 -12,2 37.87% | -5,02 -10,1 50.21% | -8,94 | -9,47 | -8,74 | 3,21 | |
|
Net income Million USD | Released Forecast Spread | -32,0 -22,9 -39.98% | -25,9 -6,59 -293.92% | -8,19 20,4 -140.22% | 917 -16,4 5706.31% | -10,4 -11,0 5.78% | -22,1 -18,6 -18.45% | -15,6 -12,5 -25.14% | -8,95 -11,1 19.15% | -8,51 -7,45 -14.22% | -12,5 | -10,5 | -8,61 | -1,43 | -14,6 |
|
EPS USD | Released Forecast Spread | -0,43 -0,31 -40.07% | -0,34 -0,11 -217.43% | -0,11 0,09 -226.92% | 12,1 -0,22 5618.18% | -0,15 -0,17 13.04% | -0,35 -0,25 -41.89% | -0,28 -0,21 -33.33% | -0,17 -0,21 19.05% | -0,17 -0,15 -15.91% | -0,25 | -0,21 | -0,17 | -0,03 | -0,30 |
| Announcement Date | 23/02/22 | 05/05/22 | 08/08/22 | 07/11/22 | 27/02/23 | 08/05/23 | 07/08/23 | 07/11/23 | 26/02/24 | - | - | - | - | - |
More events
Past sector events for Theravance Biopharma, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TBPH Stock
- Calendar Theravance Biopharma, Inc.
